Skip to main content

For Industry

You are here

UM Ventures Investments

University of Maryland Ventures, Baltimore invests in UMB startups based on innovative technologies with promising commercial potential. 
 
We also work closely with our startups to help expand and accelerate new business ventures. Our experienced business development team helps guide the development of go-to-market strategies and business plans, forms management teams, and identifies and helps secure funding.
  • gel-e Life Sciences

    A clinical-stage medical device company developing advanced hemostatic and wound treatment products. In 2019, gel-e received FDA Breakthrough Device...

     •  Visit Website
  • SurgiGyn, Inc.

    SurgiGYN is developing the uterine electrosurgical device (UED) to improve the safety and ease of total laparoscopic hysterectomy.

     •  Visit Website
  • NeoProgen, Inc.

    A preclinical stage company developing a novel cell-based therapy for cardiovascular disease, NeoProgen completed a $1.5M seed funding round.

     •  Visit Website
  • Living Pharma, Inc.

    Living Pharma develops Personalized CAR T Cell Therapy™. In 2017, 18 months after forming, Lentigen Technology, Inc. acquired Living Pharma.

     •  Visit Website
  • Breethe, Inc.

    Breethe is working to develop and commercialize the world's first wearable artificial lung. Since 2015, Breethe has raised more than $16 million.

     •  Visit Website
  • CoapTech

    Developing the first FDA-cleared, ultrasound-based solution for feeding tube placement, CoapTech recently received a $1.2M NIH grant.

     •  Visit Website
  • NextStep Robotics

    This early-stage company developing a personalized robotic therapy for recovering stroke patients was awarded a $1M NIH Cooperative Agreement.

     •  Visit Website
  • Harpoon Medical

    A minimally invasive, image guided surgical tool for beating heart mitral valve repair. Acquired in 2017 by Edwards Lifesciences for $100 million.

     •  Visit Website